Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?
Castera, L.; Roulot, D.; Trinchet, J.C.; Beaugrand, M.
Gastroenterologie Clinique et Biologique 25(5): 509-513
2001
ISSN/ISBN: 0399-8320 PMID: 11521104 Document Number: 538517
Document emailed within 1 workday
Related Documents
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308Chien, R.N.; Liaw, Y.F. 1993: Pathological rupture of spleen in hepatitis B virus-related cirrhosis American Journal of Gastroenterology 88(10): 1793-1795
Caccamo, L.; Belli, L.S.; Mazzaferro, V.; Colledan, M.; Alberti, A.; Regalia, E.; Fassati, L.R.; Ideo, G.; Rubino, A.; Belli, L. 1994: Milan multicenter experience in 96 liver transplants for hepatitis B virus-related cirrhosis Transplantation Proceedings 26(6): 3585-3587
Castells, L.; Esteban, J.I.; Bilbao, I.; Vargas, V.; Allende, H.; Ribera, E.; Piron, M.; Sauleda, S.; Len, O.; Pahissa, A.; Esteban, R.; Guardia, J.; Margarit, C. 2006: Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients Antiviral Therapy 11(8): 1061-1070
Fernández-Yunquera, A.; Rincón, D.; Salcedo, M.; Bañares, R. 2013: Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 26(3): 189-192
Lebray, P.; Nalpas, B.; Vallet-Pichard, A.ïs.; Broissand, C.; Sobesky, R.; Serpaggi, J.; Fontaine, H.él.èn.; Pol, S. 2005: The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virus Antiviral Therapy 10(6): 769-776
Vashakidze, E.; Imnadze, T. 2017: Combined Antiviral Treatment of Hepatitis C Virus Infection with Pegylated Interferon (Peg-Ifn) Α-2a (Pegferon) and Ribavirin (Copegus) in Inmates Georgian Medical News 264: 86-90
Levitan, B.N.; Astakhin, A.V.; Chishieva, E.M.; Afanas'ev, S.S. 2004: Serum concentration and antiviral activity of interferon alpha in chronic hepatitis and liver cirrhosis Voenno-Meditsinskii Zhurnal 325(2): 60
Chiba, T.; Matsuzaki, Y.; Abei, M.; Shoda, J.; Tanaka, N.; Osuga, T.; Aikawa, T. 1996: The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma American Journal of Gastroenterology 91(6): 1195-1203
Huang, Y.; Wu, G.; Wang, X. 1995: Analysis of hepatitis B virus X antigen expression in chronic hepatitis B and cirrhosis Zhonghua Nei Ke Za Zhi 34(4): 235-238
Leone, N.; Rizzetto, M. 2005: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma Minerva Gastroenterologica E Dietologica 51(1): 31-46
Shang, Q.; Zhang, G.; Xu, C.; Chen, C.X.; Yu, J.G.; Yan, C.Y. 2001: Expression of hepatitis B virus antigen in brain tissue from liver cirrhosis patients with hepatitis B and its significance Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 15(3): 277-279
Cacoub, P.; Saadoun, D.; Sene, D.; Limal, N.; Piette, J.-C. 2005: Treatment of hepatitis C virus-related systemic vasculitis Journal of Rheumatology 32(11): 2078-2082
Ueda, T.; Chung, H.; Kudo, M. 2011: Effects of interferon treatment on recurrence and survival after curative treatment of hepatitis C virus-related hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 319-324
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587A
Tang, Y.H. 1983: The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining Zhonghua Nei Ke Za Zhi 22(1): 17-20; 62-63
Pol, S.; Corouge, M.; Mallet, V.; Sogni, P. 2013: Rapid progression of antiviral treatments of chronic hepatitis C virus infection Minerva Gastroenterologica E Dietologica 59(2): 161-172
González González, R.L.; Roque Quintero, A.; Morier Díaz, L.; Rodríguez Lay, L.d.l.A. 2006: Evaluation of the antiviral activity of medicinal plants against the hepatitis B virus (HBV) in PLC/PRF/5 cells Revista Cubana de Medicina Tropical 58(2): 103-108
Feng, Z.; Zhou, Y.; Yao, Z. 1997: Antiviral effect of antisense oligodeoxynucleotides complementary to hepatitis B virus X gene in vitro Zhonghua Nei Ke Za Zhi 36(4): 246-249
De Almeida, A.J.é; Campos-de-Magalhães, M.; Brandão-Mello, C.E.; de Oliveira, R.V.; do Espirito-Santo, M.ár.P.; Yoshida, C.F.T.; Lampe, E. 2009: Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome Hepato-Gastroenterology 56(90): 429-436